Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).
about
Apolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisGenome-wide association study identifies a missense variant at APOA5 for coronary artery disease in Multi-Ethnic Cohorts from Southeast Asia.A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.
P2860
Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Aberrant hetero-disulfide bond ...... Cys APOA5 variant (rs2075291).
@en
Aberrant hetero-disulfide bond ...... ated p.Gly185Cys APOA5 variant
@nl
type
label
Aberrant hetero-disulfide bond ...... Cys APOA5 variant (rs2075291).
@en
Aberrant hetero-disulfide bond ...... ated p.Gly185Cys APOA5 variant
@nl
prefLabel
Aberrant hetero-disulfide bond ...... Cys APOA5 variant (rs2075291).
@en
Aberrant hetero-disulfide bond ...... ated p.Gly185Cys APOA5 variant
@nl
P2093
P2860
P1476
Aberrant hetero-disulfide bond ...... Cys APOA5 variant (rs2075291).
@en
P2093
Andrew Dykstra
Andrzej Witkowski
Clive R Pullinger
Gordon Watson
H Ewa Witkowska
Jennifer A Beckstead
John P Kane
Lisa Nelbach
Mary J Malloy
Trudy M Forte
P2860
P304
P356
10.1161/ATVBAHA.114.304027
P407
P577
2014-08-14T00:00:00Z